Russian Pharmaceutical Industry Leader
About
Products
Press center
R&D
Career
Antifraud
Export
Contacts
News
Media publications
Information materials
Terms of use
Home
Press center
News
Аll
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
BratskChemSyntez
Export
Аll
2025
2024
2023
2022
2021
2020
2019
2018
2017
23.08.2023
Nomides® suspension in new volumes
Read more
16.08.2023
The Adviser to the President and Minister of three Ministries (Science, Technology, and Education) of the Republic of Mozambique paid a working visit to Pharmasyntez-Nord JSC on the government delegation.
Read more
04.08.2023
The government delegation from the Republic of Zimbabwe visited Pharmasyntez-Nord
Read more
01.08.2023
The Pharmasyntez Group of Companies at the second Russia-Africa Summit
Read more
25.07.2023
The Pharmasyntez Group of Companies enters the Ecuador Market
Read more
24.07.2023
The Pharmasyntez Group of Companies is in the TOP 3 pharmaceutical companies in terms of supplies in the 1st quarter of 2023
Read more
14.07.2023
Increase in cancer incidence: challenges and statistics
Read more
13.07.2023
The Pharmasyntez Group of Companies enters the Syrian Market
Read more
05.07.2023
Summer internship at the Pharmasyntez-Tyumen plant
Read more
03.07.2023
The Pharmasyntez Group of Companies starts production of gensulins in Russia
Read more
27.06.2023
"A powerful energy boost and a sense of unity"
Read more
18.06.2023
It was hot!
Read more
15.06.2023
The Pharmasyntez Group is investing 5 billion rubles in the construction of the fourth stage of the Pharmasyntez-Nord pharmaceutical complex
Read more
15.06.2023
Pharmasyntez and Irkutsk Region defined social activities for 2023
Read more
14.06.2023
The Kaluga Region and the Pharmasyntez Group of Companies signed 3 investment agreements worth more than 20 billion rubles
Read more
04.06.2023
A scholarship holder from the Pharmasyntez Group of Companies won the Grand Prix gold in Dushanbe
Read more
News:
← предыдущая
4
5
6
7
8
следующая →
About
History
Production
JSC Pharmasyntez
LLC EAST-PHARM
LLC PHARMASYNTEZ-TYUMEN
JSC PHARMASYNTEZ-NORD
LLC BratskChemSyntez
Quality management
Management
Social projects
Products
Anti-TB
Antibiotics
Cardiology
Corticoid hormones
COVID-19
Drugs for the treatment of diabetes mellitus
Endocrinology
Gynecology
HIV treatment
Infusion solutions
Injectable solutions
Local anesthetic agents
MRI agents
Multiple sclerosis
Neuroleptics
Neurology
Nonsteroidal anti-inflammatory drug
Nootropics
Oncology
Systemic mycoses
Therapeutic drugs
Transplantology
Treatment of hepatitis B
X-ray contrast agents
Сообщить о нежелательном явлении
Заполнить анкету по качеству
Press center
Pharmasyntez Group
JSC Pharmasyntez
JSC Pharmasyntez-Nord
LLC Pharmasyntez-Tyumen
LLC East-Pharm
BratskChemSyntez
Export
R&D
R&D co-operation
Intellectual property
Publications
Career
Personnel policy
Training and career development
Antifraud
Export
Possibilities
News
Contacts
Head office
Moscow Office
East-Pharm
Pharmasyntez-Tyumen
Pharmasyntez-Nord
BratskChemSyntez
Pharmasyntez-Medtech